Lv412
530 积分 2026-01-12 加入
911 Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice
7小时前
待确认
Detecting and Managing T-DXd-Related Interstitial Lung Disease: The Five "S" Rules
1天前
待确认
Impact of p16 Status on the Efficacy of Pembrolizumab Combined Nimotuzumab in Recurrent/Unresectable/Metastatic Head and Neck Squamous Cell Carcinoma Patients
7天前
已完结
Exploring the role of ITGB6: fibrosis, cancer, and other diseases
16天前
已完结
Pembrolizumab in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) and non–MSI-H/non–dMMR advanced endometrial cancer: Phase 2 KEYNOTE-158 study results
21天前
已完结
GSPT1 Functions as a Tumor Promoter in Human Liver Cancer
30天前
已完结
Development and therapeutic potential of GSPT1 molecular glue degraders: A medicinal chemistry perspective
1个月前
已完结
Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer
1个月前
已关闭
Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer
1个月前
已完结
Optimizing the safety of antibody–drug conjugates for patients with solid tumours
1个月前
已完结
皖公网安备34019202002308
